Helvetica Chimica Acta p. 525 - 538 (1998)
Update date:2022-08-03
Topics:
Boes, Michael
Stadler, Heinz
Wichmann, Juergen
Jenck, Francois
Martin, James R.
et al.
Based on O-methylasparvenone (1), a N-free 5HT2C antagonist with moderate affinity (pKi = 6.7), derivatives bearing dimethylamino (7), (dimethylamino)methyl (17, 18, 21, and 22), and aminomethyl substituents (26) in place of the benzylic OH group of 1 as well as pyrrolidine- (33) and piperidine-fused derivatives (29, 43, and 45) were synthesized.In contrast to the lead structure 1, these new ligands were active in vivo in the rat.The tricycles 33 and 45 display high affinities for the 5HT2C receptor (pKi = 8).
View MoreTaizhou Elitechemie MediPharma Technology Co.,Ltd.
Contact:+86-523-86810021
Address:Building G14,NO.1 Avenue,China Medical City, Taizhou, Jiangsu,China
Zhengzhou Institute of Chiral Pharmer Research Co., Ltd.
Contact:86-371-55219111
Address:15 Floor, 2 Building, Central China Technovalley, Zhongyuan West Road
Shanghai SMEC Trading Co., Ltd.
website:http://www.shanghaismec.com
Contact:+86-21-68811293
Address:ROOM 1101,NO.800 SHANGCHENG RD,SHANGHAI,CHINA
website:http://www.enbridgepharm.com
Contact:+86-510-83591909
Address:Huishan Zone, Wuxi City, Jiangsu Province, P.R.China
Compro Shijiazhuang Fine Chemical Co., Ltd
Contact:0086-311-89689838
Address:Economic and Technological Development Zone of Shijiazhuang,Hebei
Doi:10.1021/ja973608p
(1998)Doi:10.1021/jo01018a017
(1965)Doi:10.1016/S0957-4166(99)00358-4
(1999)Doi:10.1021/jm980007f
(1998)Doi:10.1080/07328309808002320
(1998)Doi:10.1021/acs.joc.0c01853
(2020)
